Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2009

01-09-2009 | Original Article

Protection of Regenerating Liver After Partial Hepatectomy from Carbon Tetrachloride Hepatotoxicity in Rats: Roles of Mitochondrial Uncoupling Protein 2 and ATP Stores

Authors: Qiong Wu, Dezheng Gong, Nan Tian, Liang Zhu, Lili Guan, Mei Yang, Bo Yuan, Quanfeng Qiu, Huiming Lv, Yuan Zou

Published in: Digestive Diseases and Sciences | Issue 9/2009

Login to get access

Abstract

Uncoupling protein 2 (UCP2), an inner mitochondrial membrane protein, can limit the generation of reactive oxygen species (ROS) and protect cells from injuries mediated by oxidative stress. We investigated the effect of upregulation of UCP2 in the regenerating liver 96 h after 68% partial hepatectomy (PH) on the self-protection of regenerating liver against carbon tetrachloride (CCl4) poisoning. Hepatotoxicity was induced in vivo by administering CCl4 to rats that had undergone PH. After CCl4 poisoning, the regenerating liver appeared to have less histological damage and lower serum alanine aminotransferase (ALT) levels. Lower malondialdehyde production and higher glutathione contents were also observed in the regenerating liver compared with the sham-operated liver after CCl4 poisoning. UCP2 expression was markedly elevated in the regenerating liver, and further increased after CCl4 intoxication. Mitochondrial membrane potential and adenosine triphosphate stores maintained higher levels in the regenerating liver than in sham-operated liver after CCl4 intoxication. The results showed that the regenerating liver exhibited a potent ability to resist CCl4 intoxication, and the autoprotection of regenerating liver might result from reduction of ROS by UCP2 and maintenance of higher ATP stores.
Literature
3.
go back to reference Echtay KS, Esteves TC, Pakay JL, et al. A signaling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 2003;22:4103–4110.PubMedCrossRef Echtay KS, Esteves TC, Pakay JL, et al. A signaling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 2003;22:4103–4110.PubMedCrossRef
4.
go back to reference Deierborg OT, Wieloch T, Diano S, Warden CH, Horvath TL, Mattiasson G. Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J Cereb Blood Flow Metab. 2008;6:1186–1195. doi:10.1038/jcbfm.2008.8.CrossRef Deierborg OT, Wieloch T, Diano S, Warden CH, Horvath TL, Mattiasson G. Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J Cereb Blood Flow Metab. 2008;6:1186–1195. doi:10.​1038/​jcbfm.​2008.​8.CrossRef
6.
go back to reference Duval C, Negre-Salvayre A, Dogilo A, Salvayre R, Pénicaud L, Casteilla L. Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol. 2002;80:757–764. doi:10.1139/o02-158.PubMedCrossRef Duval C, Negre-Salvayre A, Dogilo A, Salvayre R, Pénicaud L, Casteilla L. Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol. 2002;80:757–764. doi:10.​1139/​o02-158.PubMedCrossRef
11.
go back to reference Mattiasson G, Shamloo M, Gido G, et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med. 2003;9:1062–1068. doi:10.1038/nm903.PubMedCrossRef Mattiasson G, Shamloo M, Gido G, et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med. 2003;9:1062–1068. doi:10.​1038/​nm903.PubMedCrossRef
13.
go back to reference Horimoto M, Fulop P, Derdak Z, Wands JR, Baffy G. Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice. Hepatology. 2004;39:386–392.PubMedCrossRef Horimoto M, Fulop P, Derdak Z, Wands JR, Baffy G. Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice. Hepatology. 2004;39:386–392.PubMedCrossRef
14.
go back to reference Lee FY, Li Y, Zhu H, et al. Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology. 1999;29:677–687. doi:10.1002/hep.510290320.PubMedCrossRef Lee FY, Li Y, Zhu H, et al. Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology. 1999;29:677–687. doi:10.​1002/​hep.​510290320.PubMedCrossRef
15.
go back to reference Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S, Ezaki O. Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem. 2002;277:9562–9569. doi:10.1074/jbc.M110132200.PubMedCrossRef Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S, Ezaki O. Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem. 2002;277:9562–9569. doi:10.​1074/​jbc.​M110132200.PubMedCrossRef
19.
go back to reference Ugazio G, Danni O, Milillo P, Burdino E, Congiu AM. Mechanism of protection against carbon tetrachloride toxicity. I. Prevention of lethal effects by partial surgical hepatectomy. Drug Chem Toxicol. 1982;5:115–124. doi:10.3109/01480548209017773.PubMedCrossRef Ugazio G, Danni O, Milillo P, Burdino E, Congiu AM. Mechanism of protection against carbon tetrachloride toxicity. I. Prevention of lethal effects by partial surgical hepatectomy. Drug Chem Toxicol. 1982;5:115–124. doi:10.​3109/​0148054820901777​3.PubMedCrossRef
21.
go back to reference Higgins GM, Anderson RM. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol (Chic). 1931;12:186–202. Higgins GM, Anderson RM. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol (Chic). 1931;12:186–202.
28.
go back to reference Chen Z, Lash LH. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther. 1998;285:608–618.PubMed Chen Z, Lash LH. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther. 1998;285:608–618.PubMed
33.
go back to reference Short KR, Nygren J, Barazzoni R, Levine J, Nair KS. T(3) increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and -3. Am J Physiol Endocrinol Metab. 2001;280:E761–E769.PubMed Short KR, Nygren J, Barazzoni R, Levine J, Nair KS. T(3) increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and -3. Am J Physiol Endocrinol Metab. 2001;280:E761–E769.PubMed
34.
go back to reference Barazzoni R, Nair KS. Changes in uncoupling protein-2 and -3 expression in aging rat skeletal muscle, liver, and heart. Am J Physiol Endocrinol Metab. 2001;280:E413–E419.PubMed Barazzoni R, Nair KS. Changes in uncoupling protein-2 and -3 expression in aging rat skeletal muscle, liver, and heart. Am J Physiol Endocrinol Metab. 2001;280:E413–E419.PubMed
Metadata
Title
Protection of Regenerating Liver After Partial Hepatectomy from Carbon Tetrachloride Hepatotoxicity in Rats: Roles of Mitochondrial Uncoupling Protein 2 and ATP Stores
Authors
Qiong Wu
Dezheng Gong
Nan Tian
Liang Zhu
Lili Guan
Mei Yang
Bo Yuan
Quanfeng Qiu
Huiming Lv
Yuan Zou
Publication date
01-09-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0650-y

Other articles of this Issue 9/2009

Digestive Diseases and Sciences 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.